What is it about?
The use of Disease Modifying therapies for treatment in multiple sclerosis has different implications in Latin America. We present a review of costs, resources an access to MS patients in the region.
Featured Image
Why is it important?
The access to treatments in Multiple Sclerosis in latin America defines another population as the one studied in the pivotal trials, and show us the reality of this type of population
Perspectives
It is interesting to understand the situation of the patients in undeveloped countries
Eli Skromne
IMNC
Read the Original
This page is a summary of: Disease-modifying therapies in multiple sclerosis in Latin America, Multiple Sclerosis Journal - Experimental Translational and Clinical, September 2017, SAGE Publications,
DOI: 10.1177/2055217317723369.
You can read the full text:
Contributors
The following have contributed to this page
